Among the challenges is a scarcity in amoxicillin, which the Centers of Disease Control and Prevention considers a “first-line therapy” for bacterial ear infections and other common illnesses in children. The U.S. Food and Drug Administration added amoxicillin oral powder for suspension to its list of drug shortages in late October, stoking concerns among parents, pharmacists and physicians.